Accepted for Publication: October 28, 2013.
Published Online: June 25, 2014. doi:10.1001/jamadermatol.2013.9336.
Study concept and design: Lynch, McCormick, Collins.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Lynch, McCormick, Kirby, Nolan, Vellinga, Collins.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Vellinga.
Obtained funding: Lynch, Collins.
Administrative, technical, or material support: Lynch, Higgins, McCormick, Nolan, Omar, Collins.
Study supervision: Lynch, Higgins, McCormick, Kirby, Collins.
Conflict of Interest Disclosures: Professor McCormick has participated in advisory boards sponsored by Merck Sharp & Dohme, Janssen Pharmaceuticals, AbbVie, and Vifor Pharma; has been an investigator in clinical trials sponsored by Astellas Pharma, Roche, and Novartis; and has received funding for clinical research from Bayer. Professor Kirby is in receipt of unrestricted research grants from Pfizer, AbbVie, and Janssen Pharmaceuticals; is a principal investigator in clinical trials sponsored by AbbVie, Janssen Pharmaceuticals, and Merck Sharp & Dohme; and has acted as a consultant/advisory board member for Pfizer, AbbVie, Janssen Pharmaceuticals, and Roche. No other disclosures are reported.
Funding/Support: Funding for FibroTest was received from the City of Dublin Skin and Cancer Hospital Charity.